BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28671049)

  • 1. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
    Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
    Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
    Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
    Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
    Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
    World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and clinical significance of metastasis suppressor gene and matrix metalloproteinase-2 in esophageal squamous cell of carcinoma.
    Guo XQ; Li XY
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1339-42. PubMed ID: 27592483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
    Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
    Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
    Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
    Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.
    Liu W; Yu ZC; Cao WF; Ding F; Liu ZH
    World J Gastroenterol; 2006 Jun; 12(24):3929-32. PubMed ID: 16804985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
    Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
    J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of human Sel-1-like gene and its significance in esophageal cancer].
    Li H; Zhan HQ; Zhang HF
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):370-4. PubMed ID: 17822620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 14. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.
    Yan S; Zhou C; Lou X; Xiao Z; Zhu H; Wang Q; Wang Y; Lu N; He S; Zhan Q; Liu S; Xu N
    Cancer Res; 2009 Apr; 69(8):3283-90. PubMed ID: 19351864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
    Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
    Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
    Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
    Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of BRCA1 in human esophageal squamous cell carcinoma].
    Yang YX; Xue LY; Dong LJ; Fu M; Zhan QM; Tong T
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):905-9. PubMed ID: 23336376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.